| Literature DB >> 25419148 |
Salvador Piris1, Victoria Bravo1, Carmen Alvarez1, Leticia Muñoz-Hernando1, Estela Lorenzo-Hernando1, Reyes Oliver1, Laura Marqueta-Marques1, Jose M Seoane-Ruiz1, Alvaro Tejerizo-Garcia1, Jesús S Jiménez1.
Abstract
BACKGROUND: Adolescent women are a special age group affected by human papilloma virus (HPV). Most guidelines recommend surgical treatment for high-grade cytological lesions. However, some reports have attempted to demonstrate that the immune system is fully capable of clearing the virus without using conization. Our aim in this study was to describe the outcome of women <25 years old with high-grade cytology pap smears and no histologically confirmed cervical intraepithelial neoplasm [CIN] III.Entities:
Keywords: cervical intraepithelial neoplasia; conservative management; human papilloma virus
Year: 2014 PMID: 25419148 PMCID: PMC4235504 DOI: 10.2147/OTT.S69776
Source DB: PubMed Journal: Onco Targets Ther ISSN: 1178-6930 Impact factor: 4.147
Figure 1Histological cervical biopsy results.
Figure 2Type of viruses present in cervical biopsy.
Abbreviations: HPV LR, low-risk human papilloma virus; HPV HR, high-risk human papilloma virus.
Figure 3Number of HPV serotypes present in cervical biopsy.
Abbreviation: HPV, human papilloma virus.
Figure 4Cytological monitoring: different cytological results during the follow-up.
Abbreviations: ASCUS, atypical squamous cells of undetermined significance; ASCUS H, atypical squamous cells of undetermined significance high; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion.
Cytological monitoring: different cytological results during the follow-up
| % | Basal | At 3 months | At 6 months | At 9 months |
|---|---|---|---|---|
| ASCUS H | 3.6% | – | – | – |
| ASCUS | 10.7% | 12.3% | 4.3% | 4.5% |
| LSIL | 14.3% | 16% | 4.3% | – |
| HSIL | 67.9% | 20% | 4.3% | 4.5% |
| Negative | 3.6% | 36% | 39% | 22.7% |
| Absent | – | 8% | 8% | 4.5% |
Abbreviations: ASCUS, atypical squamous cells of undetermined significance; ASCUS H, atypical squamous cells of undetermined significance high; HSIL, high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion.
Figure 5Histological monitoring: histological results during the follow-up.
Abbreviation: CIN, cervical intraepithelial neoplasm.
Histological monitoring: histological results during the follow-up
| % | Basal | At 3 months | At 6 months | At 9 months |
|---|---|---|---|---|
| CIN 1 | 6.9% | – | – | – |
| CIN 1,II | 3.4% | – | – | – |
| CIN II | 41.4% | 13% | 4.5% | – |
| CIN II,III | 6.9% | – | – | – |
| CIN III | – | 8.7% | 4.5% | – |
| Negative | 24.1% | 26.1% | 9.1% | 4.8% |
Abbreviation: CIN, cervical intraepithelial neoplasm.
Microbiological monitoring: percentage of low and high oncogenic risk HPV during the follow-up period
| Basal | At 3 months | At 6 months | At 9 months | |
|---|---|---|---|---|
| High-risk serotype | ||||
| One | 34.5% | 36% | 11.5% | 11.5% |
| Various | 31% | 20% | 7.7% | 3.8% |
| Without HR | 17.2% | 16% | 15.4% | 7.7% |
| Not classified | 17.2% | – | 11.5% | 3.8% |
| Not determined | – | 20% | 53.8% | 73.1% |
| Low-risk serotype | ||||
| One | 10.3% | 26% | 7.7% | 3.8% |
| Various | 6.9% | 12% | – | – |
| Without LR | 82.8% | 48% | 42.3% | 23.1% |
| Not classified | – | – | – | – |
| Not determined | – | 16% | 50% | 73.1% |
Abbreviations: HPV, human papilloma virus; HR, high risk; LR, low risk.
Figure 6Evaluation of the CIN II during the study.
Abbreviation: CIN II, cervical intraepithelial neoplasm.